*Study of 57 sports enhancement herbal supplements published in JAMA Network Open (2023)
Continuous, indefinite administration of any research compound is rarely a good idea
Mechanism and Indications: Same Biology, Different Goals GLP-1 receptor agonists function through a well-characterized physiological pathway
Diabetologia 52 , 199207 (2009)
Manfredi Rizzo is former Director, Clinical Medical & Regulatory Department, Novo Nordisk Europe East and South and has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by pharmaceutical industry including Amgen, AstraZeneca, Boehringer Ingelheim, Kowa, Eli Lilly, Meda, Mylan, Merck Sharp & Dohme, Novo Nordisk, Novartis, Roche Diagnostics, Sanofi and Servier